Developed in India, the program is being piloted at Narayana Nethralaya Eye Institute in Bengaluru
SAP and CleaVision have announced an innovative new program aimed at reducing the risk of preventable blindness as a result of Retinopathy of Prematurity (ROP) in pre-term babies. Using the power of machine learning and data analytics, the CleaVision solution helps time-pressed doctors to arrive at a more accurate diagnosis while focusing on what’s most important treating at risk babies. Developed in India, the program is being piloted at Narayana Nethralaya Eye Institute in Bengaluru. It’s estimated that the screening program can be scaled up to further outreach and low-resource settings, minimising time to diagnosis and maximising the potential for treatment.
Chirag Gupta and Narayan V K, Co-founders, CleaVision said, “Early diagnosis is essential as most babies will recover completely if they get timely treatment for ROP. With India having the highest number of pre-mature pregnancies and the fact that there are relatively few qualified ROP practitioners, the more we can digitize and automate pre-screening, the more time those practitioners can spend on actual treatment.”
The CleaVision solution integrates image data processing with SAP Business Technology Platform, SAP AI Platform, and SAP Analytics Cloud to automate the identification of retina and blood vessel features and to make a recommendation on plus disease – a severe manifestation of ROP in premature babies. The screening data is then served to hospitals and can be reviewed by qualified medical professionals in the KIDROP (Karnataka Internet Assisted Diagnosis of ROP) telemedicine network.